Gioacchino Angarano

Best Publications

• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

  A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  785
  Citations

• Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

  Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  667
  Citations

• Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

  Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  568
  Citations

• Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men.

  Saracco A;Musicco M;Nicolosi A;Angarano G

  366
  Citations

• Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.

  M. L. Calabrò;J. Sheldon;A. Favero;G. R. Simpson

  201
  Citations

• Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

  Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  174
  Citations

• Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

  P Maggi;Am Larocca;Michele Quarto;Gabriella Serio

  174
  Citations

• Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.

  Massimo Galli;Fabrizio Veglia;Gioacchino Angarano;Sara Santambrogio

  160
  Citations

• Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.

  Matteo Bassetti;Nadia Castaldo;Annamaria Cattelan;Cristina Mussini

  156
  Citations

• Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies

  Unknown

  146
  Citations

• The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

  David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  141
  Citations

• Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

  M Milella;G Antonelli;T Santantonio;M Currenti

  133
  Citations

• Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

  Barbara Ensoli;Stefania Bellino;Antonella Tripiciano;Olimpia Longo

  123
  Citations

• Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

  Carlo F. Perno;Alessandro Cozzi-Lepri;Claudia Balotta;Federica Forbici

  120
  Citations

• Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV

  I L Simone;F Federico;C Tortorella;C F Andreula

  120
  Citations

• Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

  Antinori A;Marcotullio S;Ammassari A;Andreoni M

  118
  Citations

• Augmented Serum Neutralizing Activity against Primary Human Immunodeficiency Virus Type 1 (HIV-1) Isolates in Two Groups of HIV-1-Infected Long-Term Nonprogressors

  Yi-jun Zhang;Claudio Fracasso;José Ramon Fiore;Åsa Björndal

  111
  Citations

• Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus Load

  Cynthia M. Lyles;Maria Dorrucci;David Vlahov;Patrizio Pezzotti

  101
  Citations

• Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48-week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial.

  Francesco Mazzotta;Sergio Lo Caputo;Carlo Torti;Carmine Tinelli

  88
  Citations

• The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters.

  Rezza G;Lazzarin A;Angarano G;Sinicco A

  87
  Citations